Blood Glucose Test Strips Market to Observe Strong Development of 6.5% CAGR by 2023 | Global Key Players – ROCHE DIAGNOSTICS, LIFESCAN, BAYER HEALTHCARE, ABBOTT LABORATORIES, ARKRAY, ACON LABORATORIES, APEX BIOTECHNOLOGY

In 2017, the global blood glucose test strips market was estimated at around USD 11,000 million. The market is expected to register a CAGR of about 6.5% during 2018-2023 (the forecast period). North America, followed by Asia-Pacific, accounts for the largest share in the blood glucose test strips market.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16682
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Convenience of CGM over Conventional Monitoring
Continuous glucose monitoring (CGM) provides a frequent and real-time feedback about glucose levels and retrospective 24-hrs glucose profiles. Incorporating CGM in the treatment of type 1 diabetes (T1D) has given potential advantages over conventional self-monitoring of blood glucose (SMBG). The real-time use of CGM results can equip people with T1D and parents of youths with T1D, to respond promptly and address glycemic excursions, minimizing, both, hyperglycemia and hypoglycemia. Retrospective use of CGM profiles can reveal recurring glycemic fluctuations that are not apparent with conventional SMBG, permitting regimen adjustments to stabilize glucose control. As CGM systems have become more widespread, the market for blood glucose test strip is likely to experience growth. Moreover, owing to the rising diabetic population and technological advancements, this market is expected to grow and combat diabetes.

Key Developments in the Market
January 2018: Ascensia Diabetes Care announced the expansion of its strategic alliance with Insulet Corporation, a leader in tubeless insulin pump technology, by signing a global commercial agreement. This expansion follows the worldwide non-exclusive development agreement that Ascensia announced in June 2017, to connect its CONTOURu00aeNEXT ONE blood glucose monitoring system (BGMS) with Insulet's next-generation Omnipod System (Omnipod DASHu2122).

Major Players:
ROCHE DIAGNOSTICS, LIFESCAN, BAYER HEALTHCARE, ABBOTT LABORATORIES, ARKRAY INC., ACON LABORATORIES, APEX BIOTECHNOLOGY CORPORATION, ASCENSIA DIABETES CARE, HMD BIOMEDICAL, B. BRAUN MELSUNGEN AG amongst others.

Request Discount on this report @https://marketprognosis.com/discount-request/16682
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Cost Per Strip
Diabetes treatment requires constant monitoring of glucose levels. If blood glucose levels are not monitored regularly, it can lead to severe complications. Diabetes management process is an expensive service. At large scale, patients use blood glucose test strips. The retail cost of these strips varies from 50 cents per strip to as high as USD 5 per strip. Since, constant monitoring is necessary for diabetic patients, the cost often becomes a problem. Although various countries, like the United Kingdom, provide reimbursements for prescribed test strips, the majority patients have to pay for them from their pockets. The frequency of monitoring glucose levels depends on the type of diabetes and varies from patient to patient. For type 1 diabetes patients, at least four tests are advised per day. If the patient is using insulin injections, the count can go up to seven tests per day. Therefore, if a patient performs 5-6 tests in a day, the average expenditure on test strips would be over USD 180 each month. These expenses add to the already high diabetes management costs and are impeding the market growth.

North America to Dominate the Market Growth
North America accounted for the largest share of 56% of the global market, owing to the availability of healthcare reimbursements and the fastest adoption rate for new medical technologies. Europe is also the leading region in the global blood glucose test strips market. Asia-Pacific is the fastest growing region for blood glucose test strips market and portrays a huge potential for growth in the future, due to the increasing government initiatives to combat diabetes and corporate investments to streamline R&D in diabetes.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/16682
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No:+1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.